Stay updated on Milademetan Safety in AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Milademetan Safety in AML/MDS Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision line now displays Revision: v3.5.4, and the prior Revision: v3.5.3 entry was removed, reflecting a minor update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-05-15T03:09:49.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s revision identifier has been updated to v3.5.3, replacing the previous v3.5.2. This reflects a platform update without changes to the shown study details.
    Difference
    0.0%
    Check dated 2026-04-30T18:41:33.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:43:19.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added Acute myeloid leukemia as a listed condition/keyword on the study page.
    Difference
    0.0%
    Check dated 2026-04-02T00:35:25.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T17:54:15.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T15:49:49.000Z thumbnail image

Stay in the know with updates to Milademetan Safety in AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.